ChainCatcher News, Core Scientific has sold $500 million worth of 2031 convertible senior notes to qualified institutional buyers in a private placement. Core Scientific also intends to grant the initial purchasers of the notes the right to purchase additional options for settlement within 13 days (including the day of the initial issuance) of the notes, with a maximum additional purchase of $75 million principal.
Core Scientific tiene la intención de utilizar los ingresos netos de esta emisión para fines generales de la empresa, incluyendo capital de trabajo, gastos operativos, gastos de capital, adquisición de negocios complementarios o recompra de sus valores.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Core Scientific planea emitir $500 millones de notas convertibles preferentes
ChainCatcher News, Core Scientific has sold $500 million worth of 2031 convertible senior notes to qualified institutional buyers in a private placement. Core Scientific also intends to grant the initial purchasers of the notes the right to purchase additional options for settlement within 13 days (including the day of the initial issuance) of the notes, with a maximum additional purchase of $75 million principal. Core Scientific tiene la intención de utilizar los ingresos netos de esta emisión para fines generales de la empresa, incluyendo capital de trabajo, gastos operativos, gastos de capital, adquisición de negocios complementarios o recompra de sus valores.